AA
TRLV

Ancora Advisors’s Trulieve Cannabis Corp TRLV Stock Holding History

Ancora Advisors’s Portfolio TRLV Stock Details TRLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-469
Closed -$4K – 2282
2022
Q4 		$4K Buy
+469
New +$4K ﹤0.01% 1528

Other funds holding TRLV

ADMI
Albert D. Mason Inc Boston, Massachusetts $176M AUM 40.3% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
CH
Canton Hathaway Providence, Rhode Island $522M AUM 25.81% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
HCM
Horrell Capital Management Little Rock, Arkansas $219M AUM 21.7% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.91B AUM 24.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return

Ancora Advisors's TRLV Position: Q1 2023 in Review

Ancora Advisors sold out of Trulieve Cannabis Corp (TRLV) in Q1 2023, closing a stake of 469 shares — an estimated $4K sold.

Ancora Advisors first reported a position in TRLV in Q4 2022 and held it in 1 quarter. The position peaked at $4K in Q4 2022. 11 funds tracked by Wall St. Rank hold TRLV as of Q1 2023.

  • Ancora Advisors reported no remaining Trulieve Cannabis Corp position as of Q1 2023 after selling out during the quarter.
  • Ancora Advisors sold 469 Trulieve Cannabis Corp shares in Q1 2023, an estimated $4K.
  • Ancora Advisors first reported a position in Trulieve Cannabis Corp in Q4 2022 and held it in 1 quarter.
  • Ancora Advisors's Trulieve Cannabis Corp position peaked at $4K in Q4 2022.
  • 11 funds tracked by Wall St. Rank held Trulieve Cannabis Corp as of Q1 2023.

Based on Ancora Advisors's 13F filing for Q1 2023, filed 16 May 2023.